Dendritic cell infiltration in colon cancer

Area of Science:

• Immunology
• Oncology
• Cancer Research

Background:

• Dendritic cells (DCs) are crucial immune cells that play a role in initiating anti-tumor responses.
• Understanding DC infiltration in colorectal cancer (CRC) is important for developing effective immunotherapies.
• The phenotype and density of DCs in primary and metastatic CRC are not fully characterized.

Purpose of the Study:

• To quantitatively evaluate the infiltration and phenotype of dendritic cells (DCs) in primary and metastatic colorectal cancers.
• To investigate the relationship between DC density and the expression of specific cytokines and growth factors within the tumor microenvironment.

Main Methods:

• Immunohistochemistry was used to assess the density and phenotype of DCs (CD83, HLA-DR, CD40, CD86) in 44 primary CRC tumors and 13 metastatic tumors.
• Expression levels of cytokines (interleukin-10, transforming growth factor beta, vascular endothelial growth factor) and tumor necrosis factor (TNF) by tumor-infiltrating lymphocytes (TILs) and tumor cells were evaluated.

Main Results:

• DCs infiltrating CRC tumors exhibited a mature phenotype (CD83+, HLA-DR+, CD40+, CD86+).
• DC density was significantly lower in primary CRC (0.29 cells/hpf) compared to normal colonic mucosa (0.84 cells/hpf) and markedly reduced in metastases (0.05 cells/hpf).
• Tumor expression of vascular endothelial growth factor (VEGF) was associated with increased DC density (p=0.01), and high TNF expression by TILs correlated with greater mature DC density (p<0.01).

Conclusions:

• Dendritic cell infiltration is significantly impaired in colorectal cancer, particularly in metastatic sites.
• Tumor microenvironment factors like VEGF and TNF may influence DC recruitment and maturation in CRC.
• These findings highlight potential therapeutic targets to enhance anti-tumor immunity in colorectal cancer.